Whistleblower Law Safe From US Supreme Court For Now
The United States Supreme Court declined to hear Eli Lilly’s appeal against the constitutionality of the False Claims Act, which it pursued in order to avoid accountability for Medicaid fraud.
In 2022, a jury ordered the multinational pharmaceutical corporation to pay $61 million after whistleblower Ronald Streck alleged that the company had underpaid rebates that drug manufacturers must pay as part of Medicaid. Since damages were trebled and interest accrued, Eli Lilly was instructed to pay over $220 million.